We are live on
!
Find out more
CA
Cornerstone Advisors Portfolio holdings
AUM
$3.04B
Turnover
28.46%
1-Year Est. Return
36.62%
This Fund
S&P 500
This Quarter
Est. Return
+3.84%
1 Year Est. Return
+36.62%
3 Year Est. Return
+108.19%
5 Year Est. Return
+137.76%
10 Year Est. Return
–
AUM
$545M
AUM Growth
-$8.77M
(-1.6%)
Cap. Flow
-$25.2M
Cap. Flow
% of AUM
-4.62%
Top 10 Holdings %
Top 10 Hldgs %
23.67%
Holding
270
New
49
Increased
48
Reduced
49
Closed
37
Avg Time Held
1.2
years
Top 10 Avg Time Held
0.8
years
Top 20 Avg Time Held
1.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$10.3M |
| 2 |
UnitedHealth
UNH
|
+$5.44M |
| 3 |
Boeing
BA
|
+$3.72M |
| 4 |
Comcast
CMCSA
|
+$3M |
| 5 |
Honeywell
HON
|
+$2.48M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$6.63M |
| 2 |
Morgan Stanley China A Share Fund
CAF
|
+$6.28M |
| 3 |
Merck
MRK
|
+$5.74M |
| 4 |
Philip Morris
PM
|
+$4.97M |
| 5 |
Chevron
CVX
|
+$4.96M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 29.38% |
| 2 | Financials | 13.1% |
| 3 | Healthcare | 11.1% |
| 4 | Communication Services | 9.75% |
| 5 | Technology | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
151
Central and Eastern Europe Fund
CEE
$122M
| $862K | 0.16% |
39,343
+21,069
| +115% | +$454K |
2017 Q1
1 quarter
|
|
152
Charles Schwab
SCHW
$163B
| $859K | 0.16% |
+20,000
| New | +$801K |
2017 Q2
0 quarters
|
|
153
Aflac
AFL
$59.2B
| $854K | 0.16% |
22,000
| – | – |
2016 Q2
4 quarters
|
|
154
Sprott Focus Trust
FUND
$290M
| $815K | 0.15% |
110,420
+25,352
| +30% | +$190K |
2015 Q1
9 quarters
|
|
155
Viatris
VTRS
$20.9B
| $815K | 0.15% |
21,000
+10,000
| +91% | +$384K |
2017 Q1
1 quarter
|
|
156
Tyson Foods
TSN
$19B
| $814K | 0.15% |
+13,000
| New | +$797K |
2017 Q2
0 quarters
|
|
157
Japan Smaller Capitalization Fund
JOF
$346M
| $800K | 0.15% |
69,701
+14,445
| +26% | +$162K |
2016 Q1
5 quarters
|
|
158
DELISTED
Pioneer Natural Resource Co.
PXD
| $798K | 0.15% |
5,000
| – | – |
2016 Q2
4 quarters
|
|
159
Aptiv
APTV
$9.38B
| $789K | 0.14% |
9,000
| – | – |
2016 Q4
2 quarters
|
|
160
Applied Materials
AMAT
$341B
| $785K | 0.14% |
+19,000
| New | +$807K |
2017 Q2
0 quarters
|
|
|
GCH
161
DELISTED
Aberdeen Greater China Fund
GCH
| $772K | 0.14% |
67,343
-34,120
| -34% | -$371K |
2013 Q2
16 quarters
|
|
|
SGF
162
DELISTED
Aberdeen Singapore Fund
SGF
| $733K | 0.13% |
66,438
-11,563
| -15% | -$128K |
2013 Q2
16 quarters
|
|
163
PACCAR
PCAR
$58.3B
| $726K | 0.13% |
16,500
+6,000
| +57% | +$259K |
2017 Q1
1 quarter
|
|
164
Humana
HUM
$51.9B
| $722K | 0.13% |
+3,000
| New | +$679K |
2017 Q2
0 quarters
|
|
165
New Germany Fund
GF
$167M
| $714K | 0.13% |
42,943
+12,422
| +41% | +$200K |
2016 Q4
2 quarters
|
|
|
TWX
166
DELISTED
Time Warner Inc
TWX
| $703K | 0.13% |
7,000
| – | – |
2016 Q4
2 quarters
|
|
167
Sherwin-Williams
SHW
$81.8B
| $702K | 0.13% |
+6,000
| New | +$670K |
2017 Q2
0 quarters
|
|
168
Republic Services
RSG
$70.3B
| $701K | 0.13% |
+11,000
| New | +$696K |
2017 Q2
0 quarters
|
|
169
HCA Healthcare
HCA
$101B
| $698K | 0.13% |
+8,000
| New | +$677K |
2017 Q2
0 quarters
|
|
170
Edison International
EIX
$21.4B
| $688K | 0.13% |
+8,800
| New | +$705K |
2017 Q2
0 quarters
|
|
|
TFCFA
171
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $680K | 0.12% |
24,000
-14,000
| -37% | -$403K |
2016 Q4
2 quarters
|
|
172
Cognizant
CTSH
$29.6B
| $664K | 0.12% |
10,000
| – | – |
2017 Q1
1 quarter
|
|
173
General Mills
GIS
$17.6B
| $659K | 0.12% |
11,900
+3,000
| +34% | +$171K |
2016 Q1
5 quarters
|
|
|
BHI
174
DELISTED
Baker Hughes
BHI
| $654K | 0.12% |
12,000
| – | – |
2016 Q4
2 quarters
|
|
175
Vertex Pharmaceuticals
VRTX
$129B
| $644K | 0.12% |
+5,000
| New | +$602K |
2017 Q2
0 quarters
|
|
Similar funds
GFA
SL
JFGIW
Cornerstone Advisors's Q2 2017 Portfolio in Review
As of Q2 2017, Cornerstone Advisors held 270 positions worth $545M, down 1.6% from $554M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Cornerstone Advisors withdrew a net $25.2M in Q2 2017, closing 37 positions and reducing 49 holdings. Its most notable exit was Pfizer, an estimated $6.63M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 29% of assets, down from 35% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Cornerstone Advisors opened a new position in Meta Platforms (Facebook) worth $10.5M.
- Cornerstone Advisors's largest Q2 2017 buy was Meta Platforms (Facebook): 69,500 shares worth $10.5M.
- Cornerstone Advisors added most to CVS Health in Q2 2017, an estimated $2.29M increase.
- Cornerstone Advisors's biggest Q2 2017 reduction was Morgan Stanley China A Share Fund, cutting an estimated $6.28M.
- Cornerstone Advisors fully exited Pfizer in Q2 2017, selling an estimated $6.63M.
- Cornerstone Advisors's ten largest holdings make up 24% of its $545M portfolio in Q2 2017.
- Cornerstone Advisors opened 49 new positions and closed 37 in Q2 2017.
- Cornerstone Advisors's portfolio value fell 1.6% quarter-over-quarter to $545M.
Based on Cornerstone Advisors's 13F filing for Q2 2017, filed 10 Aug 2017.